Clinical Trial Update: Utilization and Safety of the Mk II Inserter and the Safety of the FAI Insert in Non-Infectious Uveitis [Phase 3]

View source ↗

Summary

Phase 3 trial update on the Mk II Inserter and FAI Insert safety in non-infectious uveitis; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-infectious Uveitis

Drugs mentioned

• FAI insert
• Mk II Inserter

Snippet

Sponsor: EyePoint Pharmaceuticals, Inc. | Conditions: Non-Infectious Uveitis | Phase 3 | Status: COMPLETED | Results posted: 2020-05-01